Latest CHI Advisors LLC Stock Portfolio
$252Million
About CHI Advisors LLC and 13F Hedge Fund Stock Holdings
CHI Advisors LLC is a hedge fund based in New York, NY. On 2023-11-13, the fund reported it's updated stock portfolio. In the 13F Holdings report, CHI Advisors LLC reported an equity portfolio of $252.3 Millions as of 30 Sep, 2023. <br><br> The top stock holdings of CHI Advisors LLC are PLRX, RPTX, CGEM. The fund has invested 20.7% of it's portfolio in PLIANT THERAPEUTICS INC and 14.2% of portfolio in REPARE THERAPEUTICS INC. <br><br> The fund managers got completely rid off VECTIVBIO HLDG AG, HOOKIPA PHARMA INC (HOOK) and CORVUS PHARMACEUTICALS INC (CRVS) stocks. They significantly reduced their stock positions in DISC MEDICINE INC, PRECISION BIOSCIENCES INC (DTIL) and DIREXION SHS ETF TR (GUSH). CHI Advisors LLC opened new stock positions in MINERALYS THERAPEUTICS INC, BLUEPRINT MEDICINES CORP (BPMC) and MOONLAKE IMMUNOTHERAPEUTICS (MLTX). The fund showed a lot of confidence in some stocks as they added substantially to ORCHARD THERAPEUTICS PLC (ORTX), FREELINE THERAPEUTICS HLDGS and ULTRAGENYX PHARMACEUTICAL IN (RARE).
CHI Advisors LLC Equity Portfolio Value
Last Reported on: 13 Nov, 2023
$252Million
as of Nov 13, 2023New Buys
| Ticker | $ Bought |
|---|---|
| mineralys therapeutics inc | 5,405,280 |
| blueprint medicines corp | 4,664,840 |
| moonlake immunotherapeutics | 3,420,000 |
| sagimet biosciences inc | 3,069,810 |
New stocks bought by CHI Advisors LLC
Additions
| Ticker | % Inc. |
|---|---|
| orchard therapeutics plc | 1,529 |
| freeline therapeutics hldgs | 299 |
| ultragenyx pharmaceutical in | 152 |
| syros pharmaceuticals inc | 69.31 |
| 2seventy bio inc | 17.61 |
| inozyme pharma inc | 6.28 |
| ikena oncology inc | 2.78 |
| keros therapeutics inc | 1.37 |
Additions to existing portfolio by CHI Advisors LLC
Reductions
| Ticker | % Reduced |
|---|---|
| disc medicine inc | -80.02 |
| precision biosciences inc | -62.17 |
| direxion shs etf tr | -30.77 |
| rallybio corp | -28.01 |
| acelyrin inc | -15.05 |
| black diamond therapeutics i | -4.00 |
| pliant therapeutics inc | -3.3 |
| repare therapeutics inc | -1.07 |
CHI Advisors LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| vectivbio hldg ag | -46,945,100 |
| hookipa pharma inc | -694,091 |
| corvus pharmaceuticals inc | -458,000 |
CHI Advisors LLC got rid off the above stocks
CHI Advisors LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of CHI Advisors LLC
$252.09MTotal Value
29.00Positions
13 Nov, 2023Last Reported
| Expand | Holdingsorted ascending | % Portfolio | Shares Held | $ Value | % Change |
|---|---|---|---|---|---|
 Black Diamond Therapeutics I CHI Advisors LLC's holding in Black Diamond Therapeutics I over time | 0.82% | 720,000 | $2.07M 0.82% | 4%decreased 4 percentreduced | |
 Blueprint Medicines Corp CHI Advisors LLC's holding in Blueprint Medicines Corp over time | 1.85% | 92,888 | $4.66M 1.85% | Newnew position | |
 Cullinan Oncology Inc CHI Advisors LLC's holding in Cullinan Oncology Inc over time | 12.25% | 3,414,190 | $30.90M 12.25% | 0%unchanged 0 percentunchanged | |
 Compass Therapeutics Inc CHI Advisors LLC's holding in Compass Therapeutics Inc over time | 2.21% | 2,829,710 | $5.57M 2.21% | 0%unchanged 0 percentunchanged | |
 Corvus Pharmaceuticals Inc CHI Advisors LLC's holding in Corvus Pharmaceuticals Inc over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
 Precision Biosciences Inc CHI Advisors LLC's holding in Precision Biosciences Inc over time | 0.08% | 606,629 | $207.0K 0.08% | 62.17%decreased 62.17 percentreduced | |
 Graphite Bio Inc Graphite Bio IncGRPH CHI Advisors LLC's holding in Graphite Bio Inc over time | 0.23% | 230,938 | $572.7K 0.23% | 0%unchanged 0 percentunchanged | |
 GUSH Direxion Shs Etf TrDirexion Shs Etf TrGUSH | 1.84% | 225,000 | $4.63M 1.84% | 30.77%decreased 30.77 percentreduced | |
 Hookipa Pharma Inc CHI Advisors LLC's holding in Hookipa Pharma Inc over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
 Ikena Oncology Inc CHI Advisors LLC's holding in Ikena Oncology Inc over time | 3.74% | 2,180,930 | $9.44M 3.74% | 2.78%increased 2.78 percentadded | |
 Inozyme Pharma Inc CHI Advisors LLC's holding in Inozyme Pharma Inc over time | 2.11% | 1,270,030 | $5.33M 2.11% | 6.28%increased 6.28 percentadded | |
 Keros Therapeutics Inc CHI Advisors LLC's holding in Keros Therapeutics Inc over time | 5.15% | 407,633 | $13.00M 5.15% | 1.37%increased 1.37 percentadded | |
 Larimar Therapeutics Inc CHI Advisors LLC's holding in Larimar Therapeutics Inc over time | 5.35% | 3,414,470 | $13.49M 5.35% | 0%unchanged 0 percentunchanged | |
 Moonlake Immunotherapeutics CHI Advisors LLC's holding in Moonlake Immunotherapeutics over time | 1.35% | 60,000 | $3.42M 1.35% | Newnew position | |
 Omega Therapeutics Inc CHI Advisors LLC's holding in Omega Therapeutics Inc over time | 0.9% | 1,055,880 | $2.27M 0.9% | 0%unchanged 0 percentunchanged | |
 Orchard Therapeutics Plc CHI Advisors LLC's holding in Orchard Therapeutics Plc over time | 5.56% | 12,315,700 | $14.03M 5.56% | 1529.62%increased 1529.62 percentadded | |
 Ovid Therapeutics Inc CHI Advisors LLC's holding in Ovid Therapeutics Inc over time | 1.32% | 864,822 | $3.32M 1.32% | 0%unchanged 0 percentunchanged | |
 Pliant Therapeutics Inc CHI Advisors LLC's holding in Pliant Therapeutics Inc over time | 20.72% | 3,014,200 | $52.27M 20.72% | 3.3%decreased 3.3 percentreduced | |
 Ultragenyx Pharmaceutical In CHI Advisors LLC's holding in Ultragenyx Pharmaceutical In over time | 3.04% | 215,000 | $7.66M 3.04% | 152.94%increased 152.94 percentadded | |
 Rallybio Corp Rallybio CorpRLYB CHI Advisors LLC's holding in Rallybio Corp over time | 0.52% | 390,734 | $1.32M 0.52% | 28.01%decreased 28.01 percentreduced | |